Novlead Biotech Overview
- Year Founded
-
2018
- Status
-
IPO Registration
- Employees
-
158
- Latest Deal Type
-
IPO
- (Announced)
- Investors
-
18
Novlead Biotech General Information
Description
Developer and manufacturer of medical devices designed for cardiopulmonary, respiratory and anti-infection fields. The company focuses on the medical application of nitric oxide (NO) to treat pulmonary hypertension and infectious diseases, enabling hospitals to improve treatment efficiency and quality of patient's life.
Contact Information
Website
www.novlead.comCorporate Office
- Nanjing Jiangbei New Area R&D and Production Headquarters
- Nanjing, Jiangsu 211800
- China
Corporate Office
- Nanjing Jiangbei New Area R&D and Production Headquarters
- Nanjing, Jiangsu 211800
- China
Novlead Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. IPO | 20-Feb-2026 | Announced | Clinical Trials - General | |||
| 7. Later Stage VC (Series C) | 20-Feb-2024 | Completed | Clinical Trials - General | |||
| 6. Early Stage VC (Series B1) | 08-Sep-2022 | Completed | Clinical Trials - General | |||
| 5. Early Stage VC (Series B) | 15-Nov-2021 | Completed | Pre-Clinical Trials | |||
| 4. Early Stage VC (Series A) | 19-Dec-2020 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC | 26-Apr-2020 | Completed | Product Development | |||
| 2. Secondary Transaction - Private | 21-Feb-2020 | Completed | Product Development | |||
| 1. Merger/Acquisition | 06-Mar-2019 | $44.5K | Completed | Product Development |
Novlead Biotech Patents
Novlead Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4724126-A1 | Apparatuses, systems, and methods for transmitting therapeutic gas | Pending | 06-Jun-2023 | ||
| US-20260325771-A1 | Apparatuses, systems, and methods for transmitting therapeutic gas | Pending | 06-Jun-2023 | ||
| WO-2024251144-A1 | Apparatuses, systems, and methods for transmitting therapeutic gas | Inactive | 06-Jun-2023 | ||
| AU-2023416236-A1 | On-demand nitric oxide generation and delivery devices | Pending | 28-Dec-2022 | ||
| EP-4642956-A1 | On-demand nitric oxide generation and delivery devices | Pending | 28-Dec-2022 | C25B1/01 |
Novlead Biotech Signals
Novlead Biotech Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Innovation Partnerships | Venture Capital | Minority | ||
| Jiangsu Dingxin Capital Management | Venture Capital | Minority | ||
| Shenzhen Yifeng Investment Management Enterprise | Venture Capital | Minority | ||
| Triwise Capital | Venture Capital | Minority | ||
| Xingxiang Investment Holding Group | Asset Manager | Minority |
Novlead Biotech FAQs
-
When was Novlead Biotech founded?
Novlead Biotech was founded in 2018.
-
Where is Novlead Biotech headquartered?
Novlead Biotech is headquartered in Nanjing, China.
-
What is the size of Novlead Biotech?
Novlead Biotech has 158 total employees.
-
What industry is Novlead Biotech in?
Novlead Biotech’s primary industry is Therapeutic Devices.
-
Is Novlead Biotech a private or public company?
Novlead Biotech is a Private company.
-
What is Novlead Biotech’s current revenue?
The current revenue for Novlead Biotech is .
-
How much funding has Novlead Biotech raised over time?
Novlead Biotech has raised $60.1M.
-
Who are Novlead Biotech’s investors?
Innovation Partnerships, Jiangsu Dingxin Capital Management, Shenzhen Yifeng Investment Management Enterprise, Triwise Capital, and Xingxiang Investment Holding Group are 5 of 18 investors who have invested in Novlead Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process